All Stories

  1. Do bismuth complexes hold promise as antileishmanial drugs?

    Article • Future Medicinal Chemistry, July 2018, Future Science

    Phil Andrews

  2. Stability and toxicity of tris-tolyl bismuth(v) dicarboxylates and their biological activity towards Leishmania major

    Article • Dalton Transactions, January 2015, Royal Society of Chemistry

    Phil Andrews

  3. Bismuth(iii) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents

    Article • Dalton Transactions, January 2014, Royal Society of Chemistry

    Phil Andrews

  4. Stability and toxicity of heteroleptic organometallic Bi(v) complexes towards Leishmania major

    Article • Dalton Transactions, January 2014, Royal Society of Chemistry

    Phil Andrews

  5. Bismuth(iii) benzohydroxamates: powerful anti-bacterial activity against Helicobacter pylori and hydrolysis to a unique Bi34 oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)

    Article • Chemical Communications, January 2014, Royal Society of Chemistry

    Phil Andrews

  6. Making Bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(iii) acetylsalicylate

    Article • Chemical Communications, January 2013, Royal Society of Chemistry

    Phil Andrews

  7. Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds

    Article • Dalton Transactions, January 2013, Royal Society of Chemistry

    Phil Andrews

  8. Sulfonato-encapsulated bismuth(iii) oxido-clusters from Bi2O3 in water under mild conditions

    Article • Chemical Communications, January 2012, Royal Society of Chemistry

    Phil Andrews